secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2026-03-31T23:59:59+00:00
Accession:  0001104659-26-037698
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Barinthus Bio principal accounting officer Gemma Jones to step down April 30, 2026
--------------------------------------------------------------------------------

- Gemma Jones, serving as principal accounting officer via CFGI, notified company of resignation effective April 30, 2026.
- No successor has been named as of the filing date.
- Jones provided services as an employee of CFGI; her departure is from the accounting officer role only.
- Company expects transition to be managed internally until a replacement is found.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465926037698/0001104659-26-037698-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465926037698/tm2610673d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-037698

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer